Related Experiment Video

Updated: May 13, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Siva1 inhibits p53 function by acting as an ARF E3 ubiquitin ligase

Xingwu Wang1, Meng Zha, Xiaocheng Zhao

  • 1Hefei National Laboratory for Physical Sciences at Microscale and School of Life Sciences, University of Science and Technology of China, Hefei, Anhui 230027, China.

Nature Communications
|March 7, 2013
PubMed

Insights

Siva1 targets the tumor suppressor alternative reading frame (ARF) for degradation, impacting the ARF-Mdm2-p53 pathway. This discovery reveals a new mechanism controlling ARF stability and cellular proliferation.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Cellular Regulation

Background:

  • The tumor suppressor alternative reading frame (ARF) is frequently mutated in human cancers.
  • ARF stabilizes and activates p53 by inhibiting Mdm2, crucial for preventing cancer.
  • Mechanisms controlling ARF levels within cells remain largely uncharacterized.

Purpose of the Study:

  • To identify regulatory factors controlling ARF stability.
  • To elucidate the role of Siva1 in ARF regulation.
  • To understand the impact of Siva1 on the ARF-Mdm2-p53 pathway and cellular processes.

Main Methods:

  • In vitro and in vivo interaction studies between Siva1 and ARF.
  • Assessment of ARF ubiquitination and degradation mediated by Siva1.
  • Analysis of p53 stability following Siva1-mediated ARF degradation.
  • Investigation of Siva1's functional role in cell cycle progression and proliferation.

Main Results:

  • Siva1 specifically binds to ARF.
  • Siva1 functions as an E3 ubiquitin ligase for ARF, promoting its ubiquitination and degradation.
  • Siva1-induced ARF degradation leads to altered p53 stability.
  • Siva1 regulates cell cycle and proliferation in an ARF/p53-dependent manner.

Conclusions:

  • Siva1 is a novel E3 ubiquitin ligase that targets ARF for degradation.
  • This interaction uncovers a new regulatory mechanism for ARF stability.
  • Siva1 plays a significant role in controlling the ARF-Mdm2-p53 pathway and cellular growth.

More Related Videos

Purification of Ubiquitinated p53 Proteins from Mammalian Cells10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...